文献速递造血干细胞移植与细胞治疗淋巴瘤白血病

CLOX与神经毒性:画钟任务在嵌合抗原受体T细胞治疗后监测免疫效应细胞相关神经毒性综合征中的效用

CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T-cell therapy.
PubMed 文献 · Br J Haematol · 2025-07-28

该研究回顾性分析了澳大利亚墨尔本The Alfred医院2022年9月至2024年2月接受CAR-T治疗的54例血液肿瘤患者,将1208份画钟任务(CDT)评分(改良CLOX量表,CLOX-M)与ICE评分在1小时内配对,评估CDT检测ICANS的效用。14例(26%)发生ICANS,CLOX-M评分较基线变化与ICE评分显著相关(ρ=0.34,p<0.001),ROC曲线下面积AUC=0.737;CLOX-M评分下降≥2分检测ICANS特异性高(0.994)但敏感性低(0.263)。CDT可作为ICE评分的补充以改善ICANS监测。

要点

  • CLOX-M评分变化与ICE评分显著相关(ρ=0.34,p<0.001)。
  • CLOX-M评分下降≥2分检测ICANS特异性0.994、敏感性0.263。
  • CDT可作为ICE评分的补充以改善ICANS监测。

核心结论

  • 画钟任务(CDT)可用于补充ICE评分以改善CAR-T治疗后ICANS的监测。

研究设计与样本

  • 回顾性研究,纳入澳大利亚墨尔本The Alfred医院2022年9月至2024年2月连续接受CAR-T治疗的54例血液肿瘤患者,回顾病历评估ICANS及ICE评分与CLOX-M评分变化。
  • 共1208份画钟图在ICE评分1小时内进行时间配对,患者39%为女性,年龄64.36±13.25岁。

主要发现

  • 54例患者中14例(26%)发生ICANS。
  • CLOX-M评分较基线变化与ICE评分显著相关(ρ=0.34,p<0.001)。
  • ROC分析显示CLOX-M评分具有中等判别能力(AUC=0.737)。
  • CLOX-M评分下降≥2分检测ICANS特异性0.994、敏感性0.263。

关键数值与推荐

  • CLOX-M评分下降≥2分检测ICANS:特异性0.994,敏感性0.263。
  • CLOX-M评分ROC曲线下面积AUC=0.737。
  • CLOX-M评分变化与ICE评分相关系数ρ=0.34,p<0.001。

临床怎么用

  • 作者认为CDT可用于补充ICE评分以改善ICANS监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune effector cell-associated neurotoxicity syndrome (ICANS)-associated cognitive impairment is common in patients who receive chimeric antigen receptor T-cell (CAR-T) therapy. This study evaluated the utility of the clock drawing task (CDT) in detecting ICANS in patients with haematological cancers following CAR-T therapy. Data were collected from CAR-T patients at The Alfred Hospital, Melbourne, Australia. Patients underwent frequent assessments using the immune effector cell-associated encephalopathy (ICE) score and the CDT, scored using a modified CLOX (CLOX-M) rating scale, during their admission. We retrospectively reviewed the medical records of consecutive patients who received CAR-T therapy between September 2022 and February 2024 to assess for ICANS and changes in ICE score and CLOX-M. A total of 1208 clock drawings were time matched within an hour of an ICE score for 54 patients (39% female, 64.36 ± 13.25 years). Fourteen (26%) patients developed ICANS. Change in CLOX-M scores from baseline and ICE scores was significantly correlated (ρ = 0.34, p < 0.001). Receiver operating characteristic (ROC) analysis demonstrated that the CLOX-M score has moderate discriminatory power (Area Under the Curve [AUC] = 0.737). A decrease in CLOX-M score of 2 or more had high specificity (0.994) but low sensitivity (0.263) for detecting ICANS. The CDT can be used to complement the ICE score to improve ICANS monitoring.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Kazzi C, Simpson T, Wronski M, et al. CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T-cell therapy. Br J Haematol. 2025. PMID: 40717546. doi:10.1111/bjh.70044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。